VK
Vivek Khandelwal
About Vivek Khandelwal
Data last updated:
Vivek Khandelwal is a Director at Khandelwal Hospital And Urology Centre Private Limited (since 2017) and Director at Corona Pharmaceuticals Private Limited (since 2023). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹13.17 Cr; the largest is Khandelwal Hospital And Urology Centre Private Limited at ₹7.16 Cr (FY 2024). Earlier, Vivek Khandelwal was a Director at Servio Dialysis Clinix Private Limited (2019–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Khandelwal Hospital And Urology Centre Private Limited U74999DL2017PTC318246 | Director | 26 May 2017 | 2017 | ₹7.16 Cr (FY 2024) | Active |
 Corona Pharmaceuticals Private Limited U85100UR2008PTC032700 | Director | 31 Jul 2023 | 2008 | ₹6.01 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Servio Dialysis Clinix Private Limited U85320DL2018PTC342809 | Director | 01 Nov 2019 | 2018 | ₹6.19 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vivek Khandelwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Reena Khandelwal | 07771724 | Khandelwal Hospital And Urology Centre Private Limited | Director |
| Babita Dixit | 02205516 | Corona Pharmaceuticals Private Limited | Additional Director |
| Satanshu Mathur | 02456848 | Corona Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Khandelwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Khandelwal
Vivek Khandelwal currently holds 2 directorships: Khandelwal Hospital And Urology Centre Private Limited (Director, since 26 May 2017, revenue ₹7.16 Cr (FY 2024)); Corona Pharmaceuticals Private Limited (Director, since 31 Jul 2023, revenue ₹6.01 Cr (FY 2025)).
Vivek Khandelwal was first appointed on 26 May 2017 as Director at Khandelwal Hospital And Urology Centre Private Limited. The most recent appointment on record is 31 Jul 2023 at Corona Pharmaceuticals Private Limited.
The 2 current companies of Vivek Khandelwal that report revenue have a combined latest revenue of ₹13.17 Cr: Khandelwal Hospital And Urology Centre Private Limited ₹7.16 Cr (FY 2024); Corona Pharmaceuticals Private Limited ₹6.01 Cr (FY 2025).
Vivek Khandelwal held 1 earlier board appointment: Servio Dialysis Clinix Private Limited (Director, 01 Nov 2019 to 24 Sep 2024).
The current boards of Vivek Khandelwal's companies include Reena Khandelwal (Khandelwal Hospital And Urology Centre Private Limited), Babita Dixit (Corona Pharmaceuticals Private Limited), Satanshu Mathur (Corona Pharmaceuticals Private Limited).